135
Views
4
CrossRef citations to date
0
Altmetric
Original Articles

Decitabine Improves the Clinical Manifestations of Rats With l-NAME-Induced Pre-eclampsia: A Potential Approach to Studying Pre-eclampsia

, , , , , , , , , , & show all

References

  • Sibai B, Dekker G, Kupferminc M. Pre-eclampsia. Lancet 2005;365:785–99
  • Merviel P, Carbillon L, Challier JC, et al. Pathophysiology of preeclampsia: links with implantation disorders. Eur J Obstet Gynecol Reprod Biol 2004;115:134–47
  • Laresgoiti-Servitje E, Gomez-Lopez N. The pathophysiology of preeclampsia involves altered levels of angiogenic factors promoted by hypoxia and autoantibody-mediated mechanisms. Biol Reprod 2012;87:36, 1–7
  • Fisher SJ. The placental problem: linking abnormal cytotrophoblast differentiation to the maternal symptoms of preeclampsia. Reprod Biol Endocrinol 2004; 2:53, 1–4
  • Heikkilä A, Tuomisto T, Häkkinen SK, et al. Tumor suppressor and growth regulatory genes are overexpressed in severe early-onset preeclampsia – an array study on case-specific human preeclamptic placental tissue. Acta Obstet Gynecol Scand 2005;84:679–89
  • Zou Z, Anisowicz A, Hendrix MJ, et al. Maspin, a serpin with tumor-suppressing activity in human mammary epithelial cells. Science 1994;263:526–9
  • Zhang M, Magit D, Sager R. Expression of maspin in prostate cells is regulated by a positive ets element and a negative hormonal responsive element site recognized by androgen receptor. Proc Natl Acad Sci USA 1997;94:5673–8
  • Dokras A, Gardner LM, Kirschmann DA, et al. The tumour suppressor gene maspin is differentially regulated in cytotrophoblasts during human placental development. Placenta 2002;23:274–80
  • Liu Q, Qiao FY, Shi XW, et al. Promoter hypomethylation and increased maspin expression in preeclamptic placentas in a Chinese population. Placenta 2014;35:876–82
  • Shi X, Wu Y, Liu H, et al. Effect of epigenetic modification of maspin on extravillous trophoblastic function. J Huazhong Univ Sci Technolog Med Sci 2012;32:879–82
  • Atallah E, Kantarjian H, Garcia-Manero G. The role of decitabine in the treatment of myelodysplastic syndromes. Expert Opin Pharmacother 2007;8:65–73
  • Meng F, Sun G, Zhong M, et al. Inhibition of DNA methyltransferases, histone deacetylases and lysine-specific demethylase-1 suppresses the tumorigenicity of the ovarian cancer ascites cell line SKOV3. Int J Oncol 2013;43:495–502
  • Zhang H, Qi F, Cao Y, et al. 5-Aza-2′-deoxycytidine enhances maspin expression and inhibits proliferation, migration, and invasion of the bladder cancer T24 cell line. Cancer Biother Radiopharm 2013;28:343–50
  • Podjarny E, Losonczy G, Baylis C. Animal models of preeclampsia. Semin Nephrol 2004;24:596–606
  • Choi JW, Im MW, Pai SH. Nitric oxide production increases during normal pregnancy and decreases in preeclampsia. Ann Clin Lab Sci 2002;32:257–63
  • Cadnapaphornchai MA, Ohara M, Morris KG, Jr. et al. Chronic NOS inhibition reverses systemic vasodilation and glomerular hyperfiltration in pregnancy. Am J Physiol Renal Physiol 2001;280:F592–8
  • Liu W, Qiao F, Liu H, et al. Low molecular weight heparin improves proteinuria in rats with L-NAME induced preeclampsia by decreasing the expression of nephrin, but not podocin. Hypertens Pregnancy 2015;34:24–35
  • Yildirim E, Macun HC, Cinar M, et al. The effects of magnesium sulphate on the contractile activity of uterus in an animal model of preeclampsia. Clin Exp Obstet Gynecol 2014;41:169–73
  • Chen Q, Zhang Y, Tong M, et al. Pre-treatment with calcium prevents endothelial cell activation induced by multiple activators, necrotic trophoblastic debris or IL-6 or preeclamptic sera: possible relevance to the pathogenesis of preeclampsia. Placenta 2013;34:1196–201
  • Souza CO, Peracoli MT, Weel IC, et al. Hepatoprotective and anti-inflammatory effects of silibinin on experimental preeclampsia induced by L-NAME in rats. Life Sci 2012;91:159–65
  • Talebianpoor MS, Mirkhani H. The effect of tempol administration on the aortic contractile responses in rat preeclampsia model. ISRN Pharmacol 2012;2012:187–208
  • Zhao Y, Zheng YF, Luo QQ, et al. Edaravone inhibits hypoxia-induced trophoblast-soluble Fms-like tyrosine kinase 1 expression: a possible therapeutic approach to preeclampsia. Placenta 2014;35:476–82
  • Wester-Rosenlof L, Casslen V, Axelsson J, et al. A1M/alpha1-microglobulin protects from heme-induced placental and renal damage in a pregnant sheep model of preeclampsia. PLoS One 2014;9:e86353
  • Saad AF, Kechichian T, Yin H, et al. Effects of pravastatin on angiogenic and placental hypoxic imbalance in a mouse model of preeclampsia. Reprod Sci 2014;21:138–45
  • Zhang Y, Hua Z, Zhang K, et al. Therapeutic effects of anticoagulant agents on preeclampsia in a murine model induced by phosphatidylserine/phosphatidylcholine microvesicles. Placenta 2009;30:1065–70
  • Rose SL, Fitzgerald MP, White NO, et al. Epigenetic regulation of maspin expression in human ovarian carcinoma cells. Gynecol Oncol 2006;102:319–24
  • Wu Y, Alvarez M, Slamon DJ, et al. Caspase 8 and maspin are downregulated in breast cancer cells due to CpG site promoter methylation. BMC Cancer 2010;10:32, 1–12
  • Huppertz B. The anatomy of the normal placenta. J Clin Pathol 2008;61:1296–302
  • Li HW, Leung SW, Cheung AN, et al. Expression of maspin in gestational trophoblastic disease. Gynecol Oncol 2006;101:76–81

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.